Miao Sun
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2021First federal award
$7.0MFederal grants as PI7 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
7 awards · $7.0M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 14, 2025 | NIH | SBIR Phase II Preclinical Toxicology Study of Intrathecal VersaMab-101 for spinal cord injury treatment | $1.5M | VERSAPEUTICS INC |
| Sep 17, 2024 | NIH | SBIR Phase II Preclinical Toxicology Study of Intrathecal VersaMab-101 for spinal cord injury treatment | $1.4M | VERSAPEUTICS INC |
| Sep 18, 2023 | NIH | SBIR Phase II Toxicology and Efficacy Studies of Intrathecal VersaMab-101 for spinal cord injury treatment | $2.4M | VERSAPEUTICS INC |
| Sep 15, 2023 | NIH | SBIR Phase I Developing therapeutic antibodies for Alzheimer's disease | $490K | VERSAPEUTICS INC |
| Aug 1, 2022 | NIH | SBIR Phase I Developing therapeutic antibodies for Alzheimer's disease | $499K | VERSAPEUTICS INC |
| Apr 1, 2022 | NIH | SBIR Phase I Pharmacokinetics and efficacy of intrathecal VersaMab-101 delivery foracute spinal cord injury | $495K | VERSAPEUTICS INC |
| Jun 1, 2021 | NIH | SBIR Phase I Preclinical Development of VERSAMAB-101 for Spinal Cord Injury | $256K | VERSAPEUTICS INC |
Peer ranks
Federal funding#140
Awards as PI#250
Patents#273
Companies
- VERSAPEUTICS INCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.